Bacopa Monnieri
A meta-analysis of 9 RCTs (Kongkeaw et al., 2014, n=518) found Bacopa shortened Trail Making B and choice reaction times versus placebo, and two 12-week RCTs in healthy older adults (Calabrese 2008; Morgan & Stevens 2010) improved delayed word recall at 300mg/day. The newest 12-week RCT (Lopresti 2025, n=101, 300mg/day) found no effect on verbal learning, attention or working memory, though it did reduce self-reported stress. A 2026 network meta-analysis of 29 RCTs found ≥600mg/day beat 300–450mg/day for working memory. Best evidence is for delayed recall rather than acute effects.
Evidence reviewed:
Mechanism of action
Proposed mechanisms, such as antioxidant effects and effects on the acetylcholine and serotonin systems, come from animal and laboratory studies (Aguiar & Borowski 2013 review, PubMed 23772955). In a 12-week human trial, the changes in blood BDNF, malondialdehyde and acetylcholinesterase activity did not differ from placebo (Lopresti 2025, PubMed 41091332).
Clinical evidence summary
A meta-analysis of 9 RCTs (Kongkeaw et al., 2014, n=518) found Bacopa shortened Trail Making B and choice reaction times versus placebo, and two 12-week RCTs in healthy older adults (Calabrese 2008; Morgan & Stevens 2010) improved delayed word recall at 300mg/day. The newest 12-week RCT (Lopresti 2025, n=101, 300mg/day) found no effect on verbal learning, attention or working memory, though it did reduce self-reported stress. A 2026 network meta-analysis of 29 RCTs found ≥600mg/day beat 300–450mg/day for working memory. Best evidence is for delayed recall rather than acute effects.
Human effect matrix
Based on human clinical trials only. Animal and in-vitro data excluded.
| Effect | Evidence | Magnitude | Studies |
|---|---|---|---|
| Memory Consolidation | moderate | Moderate | 5 |
| Anxiety Reduction | moderate | Moderate | 2 |
| Attention | mixed | Small | 2 |
| Processing Speed | mixed | Small | 2 |
Evidence key: Strong = multiple consistent RCTs · Moderate = smaller/fewer RCTs · Preliminary = early trials or small n · Mixed = conflicting results
Documented benefits
- Delayed recall in healthy older adults (12-week RCTs)
- Anxiety and stress reduction
- Antioxidant activity (laboratory studies)
Side effects & cautions
- GI effects (increased stool frequency, abdominal cramps, nausea) reported at 300mg/day in a 12-week RCT in older adults — take with food
- More self-reported adverse reactions than placebo (digestive complaints, headaches) in a 2025 12-week RCT
- Slowed information processing initially
- Not recommended during pregnancy (precautionary: no human safety data)
How to take
Stacking recommendations
Ingredients that pair well with Bacopa Monnieri and why.
Both are studied for memory and cognitive function; we cite no trial of the pairing.
Both are studied for memory, and both are in Mind Lab Pro; we cite no trial of the pairing.
Both are studied for stress and anxiety; we cite no trial of the pairing.
Frequently asked questions
Why do some people feel "foggy" when starting Bacopa?
Slowed information processing at the start is a listed side effect of Bacopa. If it persists past 6 weeks, reduce your dose.
Do I really need to take it with fat?
It is the sensible default. Bacosides are fat-soluble compounds, and GI side effects (cramps, nausea, more frequent stools) were reported in trials, so taking Bacopa with a normal meal that contains some fat is the usual advice.
What percentage of bacosides should I look for?
Aim for at least 50%: the positive trial we cite (Calabrese et al., 2008) used 300mg a day of an extract standardised to a minimum of 50% bacosides, about 150mg of bacosides. Two standardised commercial extracts are Bacognize and Synapsa. Generic "Bacopa" with no standardisation stated is unreliable — the active compound content may be negligible.
How long does it take to work?
The positive memory trials measured outcomes after 12 weeks. This is not a supplement you evaluate in the first month. Set a calendar reminder to assess at around 12 weeks — and note that the newest 12-week trial at 300mg/day found no cognitive benefit, so results vary.
Can Bacopa be taken long-term?
Most trials ran 12 weeks or less, so controlled data beyond that is thin. Traditional Ayurvedic use is continuous without cycling, and no trial has shown cycling is necessary — but long-term safety has not been studied directly.
Top stacks containing Bacopa Monnieri
Bacopa Monnieri in Canada
Bacopa monnieri is a recognized Health Canada natural health product ingredient with its own dose entry in the "Cognitive function products" monograph, and Health Canada's Licensed Natural Health Products Database (LNHPD) lists Canadian-licensed products containing it. One example, licensed under NPN 80105758 to New Roots Herbal Inc., carries the recommended dose and use "As authorized in the NHPD monograph(s) to which the applicant attested." The monograph lists Bacopa under the uses "Helps (to) support memory" and "Helps support cognitive/brain health/function" at a standardized-extract dose, giving Canadian buyers a government-reviewed reference beyond this site's general clinical dosing guidance.
The Health Canada monograph dose
Health Canada's "Cognitive function products" monograph lists Bacopa monnieri, under the common name "Bacopa," as a standardized dry extract at "300 milligrams dried whole plant/herb top extract, per day, standardized to 40-55% bacosides." A Canadian-licensed Bacopa product that attests to this monograph is built to that preparation and dose; a product using a different preparation or a higher dose has to support it with its own evidence in the licence application rather than relying on the monograph.
A licensed Canadian example
Health Canada's LNHPD lists a licensed Bacopa monnieri product, sold under the brand names Bacopa Monnieri, Aide-Mémoire, Bacopa Memory Care and Memory Care, under NPN 80105758, held by New Roots Herbal Inc., with licence status "Active." Its recommended dose and recommended use are both listed as "As authorized in the NHPD monograph(s) to which the applicant attested" — meaning the label claim and dose trace back to the monograph(s) the applicant attested to rather than being set independently by the manufacturer.
Products in Canada
- Mind Lab Pro7.5/10No NPN found (checked 2026-10-07)Local price: ≈ $89/month
- NooCube7/10No NPN found (checked 2026-10-07)Local price: ≈ $89.99/month
- Neutonic Brain Capsules6.9/10No NPN found (checked 2026-10-19)Local price: ≈ $72/month
- Hunter Focus6.3/10No NPN found (checked 2026-10-07)
- Alpha Brain5.2/10No NPN found (checked 2026-10-07)Local price: ≈ US$53.30/month
Health Canada (NPN)
What Bacopa monnieri dose does Health Canada's monograph allow?
The "Cognitive function products" monograph lists a standardized dry extract at "300 milligrams dried whole plant/herb top extract, per day, standardized to 40-55% bacosides." That is the preparation and dose a Canadian-licensed product attesting to the monograph is built around.
How can I check if a Bacopa product sold in Canada is Health Canada licensed?
Look for an eight-digit NPN on the label and search it in Health Canada's Licensed Natural Health Products Database (LNHPD). A licensed example is NPN 80105758 (New Roots Herbal Inc.), whose LNHPD entry lists its dose and use as "As authorized in the NHPD monograph(s) to which the applicant attested."
Sources: Health Canada — Natural Health Product Monograph: Cognitive Function Products (PDF) · Health Canada — Licensed Natural Health Products Database: Bacopa Monnieri (NPN 80105758) · Health Canada — Cognitive function products monograph, Bacopa uses
Regulatory note
Natural health products available in Canada are regulated by Health Canada under the Natural Health Products Regulations. Where a product holds an NPN (Natural Product Number), Health Canada says that number "assures consumers that the product has been reviewed and approved by Health Canada for safety and efficacy"; it also states, "To be licensed in Canada, natural health products must be safe, effective, of high quality" (canada.ca, checked 2026-10-08). Cross-border imports without an NPN are not Health Canada licensed. This page is for educational purposes only and is not medical advice. Consult a qualified healthcare professional before starting any supplement.
Sources (8)expand
- PMID 24252493Meta-analysis of randomized controlled trials on cognitive effects of Bacopa monnieri extract. (2013)
- PMID 18611150Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: a randomized, double-blind, placebo-controlled trial. (2008)
- PMID 20590480Does Bacopa monnieri improve memory performance in older persons? Results of a randomized, placebo-controlled, double-blind trial. (2010)
- PMID 23281132An acute, double-blind, placebo-controlled crossover study of 320 mg and 640 mg doses of a special extract of Bacopa monnieri (CDRI 08) on sustained cognitive performance. (2012)
- PMID 41091332The Effects of a Bacopa monnieri Extract (Bacumen) on Cognition, Stress, and Fatigue in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Trial. (2025)
- PMID 41678913Comparative effects of Bacopa monnieri and Ginkgo biloba on cognitive functions: A systematic review and network meta-analysis. (2026)
- PMID 22747190The cognitive-enhancing effects of Bacopa monnieri: a systematic review of randomized, controlled human clinical trials. (2012)
- PMID 23772955Neuropharmacological review of the nootropic herb Bacopa monnieri. (2013)